Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of Schizophrenia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion Criteria:~* Inpatients with Diagnostic and Statistical Manual of Mental Disorders 4th Edition Text Revision (DSM-IV TR) diagnosis of schizophrenia, schizophreniform or schizoaffective disorder~* PANSS total score at baseline \> 75, at least two PANSS psychosis items ≥ 4, Clinical Global Impression of severity score moderately ill or more (≥4)~* Increase in the level of care (outpatient care to day clinic or inpatient care)~Exclusion Criteria:~* contraindication to study drugs

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- initial olanzapine (Type: ACTIVE_COMPARATOR): None
- initial amisulpride (Type: ACTIVE_COMPARATOR): None
- early responders (Type: ACTIVE_COMPARATOR): None
- early non-responders switched (Type: ACTIVE_COMPARATOR): None
- ealy non-responders non-switched (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).